Related references
Note: Only part of the references are listed.Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
Patricia Guyot et al.
BMC MEDICAL RESEARCH METHODOLOGY (2012)
Network meta-analysis of survival data with fractional polynomials
Jeroen P. Jansen
BMC MEDICAL RESEARCH METHODOLOGY (2011)
Cautions Regarding the Fitting and Interpretation of Survival Curves Examples from NICE Single Technology Appraisals of Drugs for Cancer
Martin Connock et al.
PHARMACOECONOMICS (2011)
Survival Time Outcomes in Randomized, Controlled Trials and Meta-Analyses: The Parallel Universes of Efficacy and Cost-Effectiveness
Patricia Guyot et al.
VALUE IN HEALTH (2011)
Survival Models in Health Economic Evaluations: Balancing Fit and Parsimony to Improve Prediction
Christopher H. Jackson et al.
INTERNATIONAL JOURNAL OF BIOSTATISTICS (2010)
Network meta-analysis of parametric survival curves
Mario J. N. M. Ouwens et al.
RESEARCH SYNTHESIS METHODS (2010)
Methodological issues in the economic analysis of cancer treatments
Paul Tappenden et al.
EUROPEAN JOURNAL OF CANCER (2006)
Bayesian evidence synthesis to extrapolate survival estimates in cost-effectiveness studies
N. Demiris et al.
STATISTICS IN MEDICINE (2006)
Survival Analysis Part III: Multivariate data analysis - choosing a model and assessing its adequacy and fit
MJ Bradburn et al.
BRITISH JOURNAL OF CANCER (2003)
Incremental net benefit in randomized clinical trials with quality-adjusted survival
AR Willan et al.
STATISTICS IN MEDICINE (2003)
Using inverse-weighting in cost-effectiveness analysis with censored data
AR Willan et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2002)
Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
P Royston et al.
STATISTICS IN MEDICINE (2002)
Incremental net benefit in randomized clinical trials
AR Willan et al.
STATISTICS IN MEDICINE (2001)
Share Paper
